Endophenotype for Alcohol Misuse in Healthy Minority Populations

PHASE4CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Healthy
Interventions
DRUG

Naltrexone

50 mg/day for two days prior to the alcohol challenge session

DRUG

placebo

placebo pills

OTHER

alcohol

190 proof alcohol prepared to 11% volume mixed with fruit juice.

OTHER

Sham alcohol

non-alcoholic placebo alcohol

Trial Locations (1)

19104

University of Pennsylvania Treatment Research Center, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER

NCT00256451 - Endophenotype for Alcohol Misuse in Healthy Minority Populations | Biotech Hunter | Biotech Hunter